337 related articles for article (PubMed ID: 28515451)
1. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
[TBL] [Abstract][Full Text] [Related]
2. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.
Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B
Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734
[TBL] [Abstract][Full Text] [Related]
3. UM-Chor1: establishment and characterization of the first validated clival chordoma cell line.
Owen JH; Komarck CM; Wang AC; Abuzeid WM; Keep RF; McKean EL; Sullivan S; Fan X; Prince MEP
J Neurosurg; 2018 Mar; 128(3):701-709. PubMed ID: 28430034
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic resection of chordomas in different clival regions.
Hong Jiang W; Ping Zhao S; Hai Xie Z; Zhang H; Zhang J; Yun Xiao J
Acta Otolaryngol; 2009 Jan; 129(1):71-83. PubMed ID: 18607890
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of clival chordomas: the transsphenoidal approach revisited.
Maira G; Pallini R; Anile C; Fernandez E; Salvinelli F; La Rocca LM; Rossi GF
J Neurosurg; 1996 Nov; 85(5):784-92. PubMed ID: 8893715
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical markers predicting long-term recurrence following clival and spinal chordoma resection: a multicenter study.
Ghaith AK; Akinduro OO; Alexander AY; Goyal A; Bon-Nieves A; de Macedo Filho L; Otamendi-Lopez A; Nathani KR; Abode-Iyamah K; Jentoft ME; Bendok BR; Clarke MJ; Link MJ; Van Gompel JJ; Quiñones-Hinojosa A; Bydon M
Neurosurg Focus; 2023 Jun; 54(6):E15. PubMed ID: 37552641
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting recurrence after resection of clival chordoma using variable surgical approaches and radiation modalities.
Jahangiri A; Chin AT; Wagner JR; Kunwar S; Ames C; Chou D; Barani I; Parsa AT; McDermott MW; Benet A; El-Sayed IH; Aghi MK
Neurosurgery; 2015 Feb; 76(2):179-85; discussion 185-6. PubMed ID: 25594191
[TBL] [Abstract][Full Text] [Related]
8. Total resection of inferiorly located sacral chordoma with posterior only approach: case report and review of the literature.
Sabuncuoglu H; Ozdogan S; Dogan H; Ataoglu O; Tımurkaynak E
Turk Neurosurg; 2010 Oct; 20(4):527-32. PubMed ID: 20963705
[TBL] [Abstract][Full Text] [Related]
9. Non-rhabdoid pediatric SMARCB1-deficient tumors: overlap between chordomas and malignant rhabdoid tumors?
Renard C; Pissaloux D; Decouvelaere AV; Bourdeaut F; Ranchère D
Cancer Genet; 2014 Sep; 207(9):384-9. PubMed ID: 25053104
[TBL] [Abstract][Full Text] [Related]
10. Clinicocytopathological spectrum, including uncommon forms, of nine cases of chordomas with immunohistochemical results, including brachyury immunostaining: A single institutional experience.
Rekhi B; Karmarkar S
Cytopathology; 2019 Mar; 30(2):229-235. PubMed ID: 30218622
[TBL] [Abstract][Full Text] [Related]
11. Chordomas: Histopathological Study in View of Anatomical Location.
Cha YJ; Suh YL
J Korean Med Sci; 2019 Apr; 34(13):e107. PubMed ID: 30950252
[TBL] [Abstract][Full Text] [Related]
12. Loss of SMARCB1/INI1 expression in poorly differentiated chordomas.
Mobley BC; McKenney JK; Bangs CD; Callahan K; Yeom KW; Schneppenheim R; Hayden MG; Cherry AM; Gokden M; Edwards MS; Fisher PG; Vogel H
Acta Neuropathol; 2010 Dec; 120(6):745-53. PubMed ID: 21057957
[TBL] [Abstract][Full Text] [Related]
13. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
Rinner B; Froehlich EV; Buerger K; Knausz H; Lohberger B; Scheipl S; Fischer C; Leithner A; Guelly C; Trajanoski S; Szuhai K; Liegl B
Int J Oncol; 2012 Feb; 40(2):443-51. PubMed ID: 22002331
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features of four rare types of chordomas, confirmed by brachyury immunostaining.
Rekhi B; Banerjee D; Ramadwar M; Bajpai J; Jambhekar NA
Indian J Pathol Microbiol; 2017; 60(3):350-354. PubMed ID: 28937370
[TBL] [Abstract][Full Text] [Related]
15. Hand metastasis from a sacral chordoma.
Emori M; Kaya M; Sugita S; Soma T; Sasaki M; Yamashita T
Ann R Coll Surg Engl; 2014 Nov; 96(8):e8-11. PubMed ID: 25350167
[TBL] [Abstract][Full Text] [Related]
16. Bone invasiveness is associated with prognosis in clivus chordomas.
Wang K; Wang L; Wu Z; Tian K; Ren C; Jia G; Zhang L; Zhang J
J Clin Neurosci; 2016 May; 27():147-52. PubMed ID: 26810468
[TBL] [Abstract][Full Text] [Related]
17. Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
Bosotti R; Magnaghi P; Di Bella S; Cozzi L; Cusi C; Bozzi F; Beltrami N; Carapezza G; Ballinari D; Amboldi N; Lupi R; Somaschini A; Raddrizzani L; Salom B; Galvani A; Stacchiotti S; Tamborini E; Isacchi A
Sci Rep; 2017 Aug; 7(1):9226. PubMed ID: 28835717
[TBL] [Abstract][Full Text] [Related]
18. Establishment of clival chordoma cell line MUG-CC1 and lymphoblastoid cells as a model for potential new treatment strategies.
Gellner V; Tomazic PV; Lohberger B; Meditz K; Heitzer E; Mokry M; Koele W; Leithner A; Liegl-Atzwanger B; Rinner B
Sci Rep; 2016 Apr; 6():24195. PubMed ID: 27072875
[TBL] [Abstract][Full Text] [Related]
19. High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesis.
Diaz RJ; Guduk M; Romagnuolo R; Smith CA; Northcott P; Shih D; Berisha F; Flanagan A; Munoz DG; Cusimano MD; Pamir MN; Rutka JT
Neoplasia; 2012 Sep; 14(9):788-98. PubMed ID: 23019410
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
